Quadricuspid aortic valve: a rare but important abnormality
0
Citation
5
Reference
10
Related Paper
Abstract:
Journal Article Quadricuspid aortic valve: a rare but important abnormality Get access Yu-Hsiang Juan, Yu-Hsiang Juan Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Linkou and Chang Gung University, Taoyuan, TaiwanNon-Invasive Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA https://orcid.org/0000-0002-1046-5309 Search for other works by this author on: Oxford Academic Google Scholar Hui Liu, Hui Liu Non-Invasive Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USADepartment of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong, Guangzhou, China Correspondence to Dr Hui Liu, Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences. No.106, Zhongshan 2 Rd, Guangzhou 510080, People’s Republic of China; liuhuijiujiu@gmail.com Search for other works by this author on: Oxford Academic Google Scholar Alfonso H Waller, Alfonso H Waller Non-Invasive Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Search for other works by this author on: Oxford Academic Google Scholar Amil M Shah, Amil M Shah Non-Invasive Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Search for other works by this author on: Oxford Academic Google Scholar Ron Blankstein Ron Blankstein Non-Invasive Cardiovascular Imaging Program, Department of Medicine (Cardiovascular Division) and Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Search for other works by this author on: Oxford Academic Google Scholar Postgraduate Medical Journal, Volume 90, Issue 1066, August 2014, Pages 482–483, https://doi.org/10.1136/postgradmedj-2014-132612 Published: 08 July 2014 Article history Received: 03 February 2014 Revision received: 24 June 2014 Accepted: 25 June 2014 Published: 08 July 2014Keywords:
General hospital
General hospital
Cite
Citations (5)
General hospital
Surgeon general
St louis
Cite
Citations (59)
*Department of Anesthesia, Critical Care and Pain Medicine, Division of Hematology, Brigham and Women's Hospital, Massachusetts General Hospital (A Teaching Affiliate of Harvard Medical School) and †Harvard Medical School at Massachusetts General Hospital, Boston, MA. Reprints: Jeanine P. Wiener-Kronish, MD, Harvard Medical School at Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114. E-mail: [email protected]. Disclosure: The authors declare no conflicts of interest.
General hospital
Cite
Citations (0)
It is particularity to nephrology specialist training program in modern medical education.The quality of nephrologists' fellowship training in Massachusetts General Hospital of Harvard Medical School has a leading position in the world.There are many feelings according to my experience during studying and working in Nephrology Department of Massachusetts General Hospital.This article gives a discussion about how to improve the nephrologists' fellowship training system in China.
General hospital
Cite
Citations (0)
No AccessJournal of UrologyAdult Urology1 Jan 2022Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Michelle M. Kim, Shulin Wu, Sharron X. Lin, Rory K. Crotty, Mukesh Harisinghani, Adam S. Feldman, Chin-Lee Wu, and Douglas M. Dahl Michelle M. KimMichelle M. Kim Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Shulin WuShulin Wu Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Sharron X. LinSharron X. Lin Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Rory K. CrottyRory K. Crotty Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Mukesh HarisinghaniMukesh Harisinghani Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , Adam S. FeldmanAdam S. Feldman Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Financial interest and/or other relationship with Janssen Pharmaceuticals, Olympus America Inc. and Vessi Medical. More articles by this author , Chin-Lee WuChin-Lee Wu †Massachusetts General Hospital, Departments of Urology and Pathology, Warren Building 225, 55 Fruit St., Boston, Massachusetts 02114 telephone: 617-726-8454; FAX: 617-726-7474; E-mail Address: [email protected] http://orcid.org/0000-0002-0444-0068 Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author , and Douglas M. DahlDouglas M. Dahl †Correspondence: Massachusetts General Hospital, Department of Urology, Gray Building 1102, 55 Fruit St., Boston, Massachusetts 02114 telephone: 617-726-0875; FAX: 617-726-6131; E-mail Address: [email protected] Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002168.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 207(1), p. 94 © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyOct 11, 2021, 12:00:00 AMEditorial CommentJournal of UrologyOct 11, 2021, 12:00:00 AMEditorial Comment Volume 207Issue 1January 2022Page: 94-94 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Michelle M. Kim Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Shulin Wu Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Sharron X. Lin Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Rory K. Crotty Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Mukesh Harisinghani Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts More articles by this author Adam S. Feldman Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Financial interest and/or other relationship with Janssen Pharmaceuticals, Olympus America Inc. and Vessi Medical. More articles by this author Chin-Lee Wu Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts †Massachusetts General Hospital, Departments of Urology and Pathology, Warren Building 225, 55 Fruit St., Boston, Massachusetts 02114 telephone: 617-726-8454; FAX: 617-726-7474; E-mail Address: [email protected] More articles by this author Douglas M. Dahl Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts †Correspondence: Massachusetts General Hospital, Department of Urology, Gray Building 1102, 55 Fruit St., Boston, Massachusetts 02114 telephone: 617-726-0875; FAX: 617-726-6131; E-mail Address: [email protected] More articles by this author Expand All Advertisement PDF DownloadLoading ...
General hospital
St louis
Cite
Citations (0)
General hospital
Cite
Citations (8)
General hospital
Cite
Citations (2)
We will try to limit our response to the rather extensive commentaries from Dr. Dupont and Dr. Baines with regard to our evaluation of the statistical power of the randomized, controlled trials of screening for breast cancer.Neither of the commentaries challenge the basic conclusions of our statistical analysis-that no trials to date have had enough patients to determine a benefit (25% mortality reduction) or lack a lack of benefit for mammographic screening in 40-49-year-old women, and, therefore, all judgments based on the randomized, controlled trials are premature.Dr. Baines recently acknowledged this when she wrote: "Those who advocate screening of women ages 40-49 years are right when they say no study thus far [including the NBSS] has had adequate power for this age group."The fact that the trials lack the statistical power to demonstrate a 25% or lower mortality reduction for women aged 40-49 years has also been the conclusion of an international panel of experts at the International Union Against Cancer meeting last year' and a jointly sponsored, American Cancer Society and National Cancer Institute meeting held in Atlanta in April 1994.Although not yet published, the most recent data, provided at the end of this response, show that when the benefit is greater than 25%, the results can be and are now "significant" (Hendrick and Smart, unpublished data).The majority of Dr. Baines' points are addressed in our paper.Dr. Baines' comparison of "detection rates" does not account for the fact that the Vancouver program does not admit symptomatic women, whereas contrary to Dr. Elwood's caution against including women with clinically evident cancers in a screening ~~
General hospital
Cite
Citations (16)